๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Desmoplastic and desmoplastic neurotropic melanoma : Experience with 280 patients

โœ Scribed by Igor Shendrik; David N. Silvers


Book ID
101229940
Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
62 KB
Volume
85
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Experience with 280 Patients I n their article on desmoplastic and desmoplastic neurotropic mel- anoma Quinn et al. 1 have extended our knowledge of this unusual subtype of melanoma. However, the authors do not address the question of whether there is any difference in the biologic behavior of desmoplastic melanoma that arises within a "conventional" melanoma, one with an atypical intraepidermal melanocytic component, and "de novo" desmoplastic melanoma, one in which there is little or no atypical intraepidermal melanocytic "precursor." This classification first was proposed by Jain and Allen in 1989 but has received little attention since. 2 We reviewed the subsequent literature including the large series of desmoplastic melanomas reported by Skelton et al. and Smithers et al. 3,4 None of these series differentiated their cases according to this classification. We believe that distinguishing between these two groups of desmoplastic melanoma is important. It is clear that the "de novo" desmoplastic melanoma is more difficult to diagnose, both clinically and histologically, than desmoplastic melanoma arising in a conventional melanoma. Therefore it is likely that the "de novo" lesions comprise the majority of desmoplastic melanomas that are treated inadequately. The delay in treatment may lead to a higher recurrence rate and thereby convey a worse prognosis for patients with this subtype of neoplasm.

We would speculate that de novo desmoplastic melanoma, if diagnosed correctly and excised adequately, may have a significantly better prognosis than conventional melanoma of comparable thickness and we would hope that Quinn et al. would be able to draw on their large series of cases to address this issue.


๐Ÿ“œ SIMILAR VOLUMES


Desmoplastic and desmoplastic neurotropi
โœ Michael J. Quinn; Kerry A. Crotty; John F. Thompson; Alan S. Coates; Christopher ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 95 KB

## Background: It has been suggested that desmoplastic melanoma (dm) and desmoplastic neurotropic melanoma (dnm) are associated with worse prognoses and higher local recurrence rates than other forms of melanoma. in the current study, a large series of patients with dm and dnm treated at a tertiary

Desmoplastic and neurotropic melanoma :
โœ Lyndon D. Su; Douglas R. Fullen; Lori Lowe; Timothy S. Wang; Jennifer L. Schwart ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 393 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND Desmoplastic and neurotropic melanoma (DNMM) occasionally metastasizes to regional lymph nodes and extranodal sites. The value of sentinel lymph node biopsy (SLNB) has not been demonstrated clearly for patients with DNMM. The authors report on the utility of SLNB in the m

Desmoplastic neurotropic melanoma of the
โœ Timothy D. Anderson; Randal S. Weber; Dupont Guerry; David Elder; Lynn Schuchter ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 162 KB ๐Ÿ‘ 1 views

## Abstract ## Background Desmoplastic neurotropic melanoma (DNM) is an uncommon cutaneous melanoma variant with pronounced neurotropism. In contrast to ordinary melanomas, locoregional recurrences are common and distant metastasis are uncommon in patients with DNM. Local control with surgery and